NCT04376619

Brief Summary

Acute kidney injury increases the risk for chronic kidney disease, length of stay, readmissions and mortality. Currently the only way to diagnose acute kidney injury is with a serum creatinine or drop in urine output. Biomarkers for acute kidney injury are well elevated before rise in creatinine. Hypothesis is that by implementing an electronic alert system with an algorithm followed by remote ischemic preconditioning will prevent acute kidney injury.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Aug 2020

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 27, 2020

Completed
9 days until next milestone

First Posted

Study publicly available on registry

May 6, 2020

Completed
3 months until next milestone

Study Start

First participant enrolled

August 1, 2020

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2021

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2021

Completed
Last Updated

October 22, 2021

Status Verified

October 1, 2021

Enrollment Period

8 months

First QC Date

April 27, 2020

Last Update Submit

October 15, 2021

Conditions

Outcome Measures

Primary Outcomes (2)

  • number of participants who developed acute kidney injury

    development of acute kidney injury as measured by serum creatinine 1.5 times more then baseline

    during hospitalization, up to three months

  • number of participants who required dialysis

    need for initiation of dialysis after acute kidney injury develops during the admission

    during hospitalization, up to three months

Secondary Outcomes (5)

  • number of participants who are placed on hospice or have expired

    at time of admission when enrolled in study to 1 year post discharge

  • progression to chronic kidney disease

    at time of admission when enrolled in study to 1 year post discharge

  • number of participants who receive dialysis

    at time of admission when enrolled in study to 1 year post discharge

  • number of participants who are readmitted

    discharged from when enrolled in study to 1 year post discharge

  • length of stay

    during hospitalization, up to three months

Study Arms (2)

KDIGO guidelines

EXPERIMENTAL

Part 1 of study, those identified as high risk for AKI then will have Kidney Disease Global Improving outcomes guideline implemented to see if this reduces incidence of AKI

Other: KDIGO guidelines

RIPC

EXPERIMENTAL

part 2 of study, those identified as high risk of AKI will have Kidney Disease Improving Global Outcomes guidelines and RIPC implemented to see if this reduces incidence of AKI compared to part 2 of study

Other: remote ischemic preconditioning

Interventions

inflation and deflation of cuff 5min each cycle repeated 3 times

RIPC

KDIGO stands for Kidney disease Improving global outcomes guidelines, and have guidelines for prevention and treatment of AKI which is considered standard of care.

KDIGO guidelines

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may not qualify if:

  • Patients who's creatinine returns to baseline after admitted can be included in study if patient still remains admitted.
  • End stage renal disease
  • estimated glomerular filtration rate less then 20
  • Left ventricular assist device patients
  • observation status
  • hospice patients
  • pregnancy
  • age less then 18
  • acute kidney injury on admission defined as 1.5 times elevated creatinine prior to last admission's creatinine
  • nephrology consult already placed
  • renal transplant or nephrectomy within 1 year
  • Patients unable to provide consent
  • symptoms or diagnosis of peripheral arterial disease
  • Patients in shock defined by requiring inotropes or vasopressors

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Acute Kidney Injury

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Study Officials

  • Shivangi Patel, M.D.

    atlantich health system

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
SEQUENTIAL
Model Details: Two part study: all patients will be triaged by alert system whether they are high risk for acute kidney injury and those patients that are identified as high risk for AKI have standard of care implemented by following kidney disease improving global outcomes guidelines in preventing AKI and part 2 will perform procedure called remote ischemic preconditioning in addition to standard of care in part1 in those patients that are identified as high risk for acute kidney injury.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 27, 2020

First Posted

May 6, 2020

Study Start

August 1, 2020

Primary Completion

April 1, 2021

Study Completion

August 1, 2021

Last Updated

October 22, 2021

Record last verified: 2021-10

Data Sharing

IPD Sharing
Will share

excel file that is password protected, only to those involved in the study directly

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
six months at end of study and for 3 more months post study completion
Access Criteria
must be involved in implementing /executing the study